Fig. 2From: Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer modelHzMUC1-MMAE inhibits the growth of pancreatic cancer cells. Capan-2, CFPAC-1, PANC-1, SW1990, and hTERT-HPNE cells were plated at low cell density and incubated with indicated concentrations of HzMUC1 antibody, human IgG-MMAE, and HzMUC1-MMAE for 5 days. Cell growth was determined by staining the plates with crystal violet and quantified by OD 540Â nm absorbance. Percent of relative cell growth was shown as the non antibody treatment was set to 100. The IC50 values are indicated. The results shown are representative of data from 3 independent experimentsBack to article page